Health Care

Proposed rule is in alignment with the Senators’ bipartisan bill to hold Big Pharma accountable for abusing the patent system WASHINGTON, D.C. – Senators Peter Welch (D-Vt.), Mike Braun (R-Ind.),and Amy Klobuchar (D-Minn.) sent a letter to Kathi Videl, Director of the U.S. Patent and…

WASHINGTON, D.C. – Today, Senator Peter Welch (D-Vt.) joined Senate Majority Leader Chuck Schumer (D-N.Y.) and his Democratic Senate colleagues on the steps of the U.S. Senate ahead of chamber’s second attempt to pass the Right to IVF Act, which was blocked today by most…

WILLISTON, VT – Today, U.S. Senator Peter Welch (D-Vt.) convened health care leaders in Williston to discuss the impact of Medicare reimbursement cuts on small and independent health care providers and businesses in Vermont, many of which are already struggling to provide care to seniors…

The 340B PATIENTS Act targets limitations on the 340B drug pricing programme to ensure that vulnerable communities can access medications. Senator Peter Welch declared a bill to curb restrictions on the 340B drug pricing programme. Credit: Bonnie Cash via Getty Images. Pharmaceutical manufacturers have been…

WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.) today introduced the bicameral 340B Pharmaceutical Access To Invest in Essential, Needed Treatments & Support (PATIENTS) Act, legislation that would protect the 340B drug pricing program and ensure patients—especially those in lower income and rural communities—can continue…